Abstract Library

#287 Lutetium-177 DOTATATE Therapy in the Management of Neuroendocrine Tumors

Introduction: Peptide receptor radionuclide therapy (PRRT) is a specific targeted treatment for NETs expressing somatostatin receptors. 177Lu-DOTATATE is one of several newly available compounds for this treatment.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Tan T, Todd J, Al-Nahhas A, Bomanji J,

Keywords: 177Lutetium-DOTATATE therapy, neuroendocrine tumor, paraganglioma, SDHB,

#275 The Use of Guar Gum in the Medical Management of Hyperinsulinaemic Hypoglycaemia

Introduction: Medical therapy, including guar gum, is frequently required in the management of patients with endogenous hyperinsulinaemic hypoglycaemia (e.g. insulinoma), especially if surgery is not appropriate.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Todd J,

Keywords: Guar gum, insulinoma, hyperinsulinaemic hypoglycaemia, pregnancy,

#224 Primary Renal Somatostatinoma with Hepatic Metastases

Introduction: Somatostatinomas are rare gastroenteropancreatic neuroendocrine tumors (GEP-NET) with a primary lesion that is invariably localized to the pancreas (40%) or duodenum or jejunum (50%).

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Carroll R, Ghaffar A, Meeran K, Todd J,

Keywords: somatostatinoma, renal, metastatic, neuroendocrine tumor,